These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18161933)

  • 1. Combined treatment of hepatocellular carcinoma with partial splenic embolization and transcatheter hepatic arterial chemoembolization.
    Huang JH; Gao F; Gu YK; Li WQ; Lu LW
    World J Gastroenterol; 2007 Dec; 13(48):6593-7. PubMed ID: 18161933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on primary hepatocellular carcinoma associated with hypersplenism treated by partial splenic embolization combined with hepatic arterial chemoembolization].
    Huang JH; Wu PH; Gu YK; Zhang FJ; Li CX; Gao F; Zhang L; Fan WJ; Li CJ
    Ai Zheng; 2006 Aug; 25(8):1003-6. PubMed ID: 16965683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Efficacy and Safety of Partial Splenic Embolization in Hepatocellular Carcinoma Patients with Thrombocytopenia Who Underwent Transarterial Chemoembolization.
    Kim NH; Kim HJ; Cho YK; Hong HP; Kim BI
    J Korean Med Sci; 2019 Aug; 34(30):e208. PubMed ID: 31373186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The significance of combined treatment for hepatocellular carcinoma with partial splenic embolization and transcatheter arterial chemoembolization using IA call/lipiodol].
    Harao M; Beppu T; Masuda T; Hayashi H; Okabe H; Okabe K; Imseung C; Komori H; Horino K; Baba H
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2027-9. PubMed ID: 19106512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial splenic embolization for hypersplenism concomitant with or after arterial embolization of hepatocellular carcinoma in 30 patients.
    Han MJ; Zhao HG; Ren K; Zhao DC; Xu K; Zhang XT
    Cardiovasc Intervent Radiol; 1997; 20(2):125-7. PubMed ID: 9030503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Splenic embolization and hepatic chemoembolization: combined transcatheter treatment of hepatocellular carcinoma in cirrhosis with hypersplenism].
    Roversi R; Ricci S; Gambari PI; Castaldini L; Rossi G; Milandri G; Formica G; Dalmonte PR
    Radiol Med; 1993 Apr; 85(4):444-9. PubMed ID: 8390705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous CSM-TACE with CalliSpheres
    Zhou J; Feng Z; Liu S; Li X; Liu Y; Gao F; Shen J; Zhang YW; Zhao GS; Zhang M
    Front Oncol; 2022; 12():998500. PubMed ID: 36530976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma.
    Miraglia R; Pietrosi G; Maruzzelli L; Petridis I; Caruso S; Marrone G; Mamone G; Vizzini G; Luca A; Gridelli B
    World J Gastroenterol; 2007 Jun; 13(21):2952-5. PubMed ID: 17589945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of clinical prognosis and the correlation between bile duct injury after transcatheter arterial chemoembolization and the level of hepatic arterial embolization in patients with hepatocellular carcinoma].
    Xu HY; Yu XP; Feng R; Hu HJ; Xiao WW
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):355-360. PubMed ID: 28535652
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of partial splenic embolization on transarterial chemoembolization for hepatocellular carcinoma with hypersplenism.
    Liu J; Wu Z; Zhang J; Xie Y; Sun P; Wu H; Chang X; Zhang L; Liu F
    Medicine (Baltimore); 2021 Jul; 100(26):e26441. PubMed ID: 34190168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter partial splenic arterial embolization in patients with hypersplenism: a clinical evaluation as supporting therapy for hepatocellular carcinoma and liver cirrhosis.
    Hirai K; Kawazoe Y; Yamashita K; Kumagai M; Tanaka M; Sakai T; Inoue R; Eguchi S; Majima Y; Abe M
    Hepatogastroenterology; 1986 Jun; 33(3):105-8. PubMed ID: 3017829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial splenic embolization using polyvinyl alcohol particles for hypersplenism in cirrhosis: a prospective randomized study.
    Zhu K; Meng X; Li Z; Huang M; Guan S; Jiang Z; Shan H
    Eur J Radiol; 2008 Apr; 66(1):100-6. PubMed ID: 17532166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic value of transcatheter arterial chemoembolization combined with portal vein embolization for primary hepatocellular carcinoma with portal vein tumor thrombus: a pilot study.
    Tan X; Xie P; Liu J; Wu H; Xie Y
    Asia Pac J Clin Oncol; 2015 Sep; 11(3):e6-e12. PubMed ID: 25228074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma.
    Rose DM; Chapman WC; Brockenbrough AT; Wright JK; Rose AT; Meranze S; Mazer M; Blair T; Blanke CD; Debelak JP; Pinson CW
    Am J Surg; 1999 May; 177(5):405-10. PubMed ID: 10365881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential transarterial chemoembolization and portal vein embolization before resection is a valid oncological strategy for unilobar hepatocellular carcinoma regardless of the tumor burden.
    Ronot M; Cauchy F; Gregoli B; Breguet R; Allaham W; Paradis V; Soubrane O; Vilgrain V
    HPB (Oxford); 2016 Aug; 18(8):684-90. PubMed ID: 27485063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study.
    Lee HS; Kim KM; Yoon JH; Lee TR; Suh KS; Lee KU; Chung JW; Park JH; Kim CY
    J Clin Oncol; 2002 Nov; 20(22):4459-65. PubMed ID: 12431969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study.
    Lee HS; Kim JS; Choi IJ; Chung JW; Park JH; Kim CY
    Cancer; 1997 Jun; 79(11):2087-94. PubMed ID: 9179054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
    Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.